Form 4: Agomab Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Naimish Patel, a Director of Agomab Therapeutics NV, received 56,328 shares of common stock on September 11, 2026.
Summary
- Grant/award: acquired 56,328 Stock Option (Right to Buy) on September 11, 2026; holds 56,328 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Naimish Patel — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Grant/award | Stock Option (Right to Buy) | 56,328 | — | — | 56,328 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Grant/award (56,328 shares) |
Keywords
insider transaction, Form 4, AGMB, AgomAb Therapeutics NV, neutral, Naimish Patel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.